Oscar Health, Inc. (OSCR) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is neutral — 2 Buy, 6 Hold, 2 Sell.
The consensus price target is $17.00 (low: $15.00, high: $18.00), representing an upside of 11.2% from the current price $15.29.
Analysts estimate Earnings Per Share (EPS) of $0.08 and revenue of $9.23B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.11 vs est $0.08 (beat +36.2%). 2025: actual $-1.69 vs est $-1.27 (missed -33%). Analyst accuracy: 74%.
OSCR Stock — 12-Month Price Forecast
$17.00
▲ +11.18% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Oscar Health, Inc., the average price target is $17.00, with a high forecast of $18.00, and a low forecast of $15.00.
The average price target represents a +11.18% change from the last price of $15.29.
Highest Price Target
$18.00
Average Price Target
$17.00
Lowest Price Target
$15.00
OSCR Analyst Ratings
Hold
Based on 10 analysts giving stock ratings to Oscar Health, Inc. in the past 3 months
EPS Estimates — OSCR
74%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.11
vs Est $0.08
▲ 26.6% off
2025
Actual –$1.69
vs Est –$1.27
▼ 24.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — OSCR
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $9.178B
vs Est $9.231B
▼ 0.6% off
2025
Actual $11.701B
vs Est $11.974B
▼ 2.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
